Our Procedure

breast microseed sources
A precise, convenient and effective breast cancer treatment option

Breast Microseed Treatment is a minimally invasive, post-lumpectomy outpatient radiation option for women with early-stage breast cancer, involving the permanent implantation of low-dose rate Pd-103 seeds. It’s proven safe and effective with more than 10 years of clinical results. Peer-reviewed publications show that outcomes are comparable to other current post-lumpectomy radiation options, and side effects are milder and less frequent.  As it’s a single outpatient procedure that’s completed in about an hour, you can offer patients the convenience of a therapy that’s One Time, One Hour. 


Key highlights:

  • One-time radiation therapy that’s more convenient for the patient

  • LDR brachytherapy for breast cancer.  Already proven to treat prostate cancer, successfully adapted for the breast 

  • Published 5-year outcomes demonstrate effectiveness comparable to external beam radiation therapy

  • Innovative, FDA-cleared device / needle guidance template

  • Ultrasound guided procedure. CT-based computer-generated treatment plan

  • Inclusion in a national patient registry

More on Our Procedure

For the first time we were
looking at ‘how can we
make your life easier’?"

Clinical Outcomes:

Peer reviews show that outcomes are similar to other forms of radiation therapy, but with reduced side effects, reduced risk of infection, and reduced damage to healthy tissue.

98% Patient Satisfaction1 

97.4% Five-year Overall Survival2

96.4% Five-year Disease-Free Survival2

1.2% Observed Local Recurrence2

97% Good or Excellent Cosmesis2

1. Pignol J-P, Rakovitch E, Keller BM, Sankreacha R, Chartier C. Tolerance and Acceptance Results of a Palladium-103 Permanent Breast Seed Implant Phase I/II Study. Int J Radiat Oncol Biol Phys. 2009; 73(5):1482-8. doi: 10.1016/j.ijrobp.2008.06.1945
2. Pignol J-P, Caudrelier J-M, Crook J, McCann C, Truong P, Verkooijen HA. Report on the Clinical Outcomes of Permanent Breast Seed Implant for Early-Stage Breast Cancers. Int J Radiat Oncol Biol Phys. 2015; 93(3):614-21. doi: 10.1016/j.ijrobp.2015.07.2266

Interested in Becoming a Provider?

If you are interested in bringing Breast Microseed Treatment® from Concure Oncology® to your hospital or clinic and would like more information, please provide us with the following information:



Concure Oncology®

Dedicated to helping you put cancer behind you so you can get back to your life faster, with the peace of mind that comes from following the appropriate breast cancer treatment to help prevent a recurrence.

Kevin Kelley
Chief Executive Officer
Jason Dyer, Vice President, U.S. Sales
Jason Dyer
Vice President, U.S. Sales

Learn More | Meet the Team

Contact Us

Concure Oncology
3010 77th Ave. SE, Suite 206
Mercer Island, WA 98040